Author:
Mahaffey Kenneth W.,Held Claes,Wojdyla Daniel M.,James Stefan K.,Katus Hugo A.,Husted Steen,Steg Philippe Gabriel,Cannon Christopher P.,Becker Richard C.,Storey Robert F.,Khurmi Nardev S.,Nicolau José C.,Yu Cheuk-Man,Ardissino Diego,Budaj Andrzej,Morais Joao,Montgomery Debra,Himmelmann Anders,Harrington Robert A.,Wallentin Lars
Funder
AstraZeneca
AstraZeneca, Merck & Co., Inc., GlaxoSmithKline, Roche, and Bristol-Myers Squibb
AstraZeneca, Eli Lilly and Company, Bristol-Myers Squibb, Terumo Inc., Medtronic, and Vascular Solutions
GlaxoSmithKline, Pfizer Inc., and Sanofi-Aventis
NYU School of Medicine, Sanofi-Aventis, and Servier
Accumetrics, AstraZeneca, CSL Behring, Essentialis, GlaxoSmithKline, Merck & Co., Inc., Regeneron, Sanofi-Aventis, and Takeda
AstraZeneca, Eli Lilly and Company/Daiichi Sankyo, and Merck & Co., Inc.
Accumetrics
Schering-Plough/Merck & Co., Inc., Bayer HealthCare, Bristol-Myers Squibb, Sanofi-Aventis, AstraZeneca, Johnson and Johnson, Roche, GlaxoSmithKline, and Novartis
AstraZeneca, Bayer HealthCare, Boston Scientific, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly and Company, GlaxoSmithKline, Menarini, Merck & Co., Inc., Pfizer Inc., and Sorin Medica
Servier
Eli Lilly and Company/Daiichi Sankyo, Merck & Co., Inc., Portola Pharmaceuticals, Sanofi-Aventis, Johnson & Johnson, Bristol-Myers Squibb, The Medicines Company, and AstraZeneca
AstraZeneca, Merck & Co., Inc., Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer Inc., and GlaxoSmithKline
AstraZeneca and Bristol-Myers Squibb/Pfizer Inc.
Subject
Cardiology and Cardiovascular Medicine